BRD4 and adrenal cortex carcinoma: Our results showed that ACC patients with low BRD3 and BRD4 expressions had longer overall survival than those with high BRD3 (P = 0.0054) (Figure 1F) and BRD4 expressions (P = 0.0066) (Figure 1H).